📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
27
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
42%
💰 Capital Raise
55%
• Critical: only 0.2 months cash remaining
📉 Score Deterioration
50%
• Score rose 43 points recently (worsening)
• Score in HIGH risk zone (65/100)
💹 Market Data
Market Cap$124.81M
Shares Outstanding10.92M
Float7.26M
Cash$10.9K
Debt$700.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 1.0% shares (2025Q4 vs prior)
35 institutional holders · 8.77M shares
#1
Karpus Management, Inc.
1.02M shares
#2
Linden Advisors LP
875.7K shares
#3
Polar Asset Management Partners Inc.
800.0K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest196
Days to Cover1.0
% of FloatN/A
FINRA data as of May 15, 2026
📁 Recent SEC Activity
8-K
8K EVENT
Apr 03, 2026
3
FORM3
Jan 20, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for IPEX
📊 IPEX FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 IPEX Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.